A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.

NCT05877924 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: NBL-020 for Injection

Sponsor

NovaRock Biotherapeutics, Ltd